Skip to main content
. 2023 Nov 15;13(11):5455–5465.

Figure 4.

Figure 4

Forest plot of PFS for subgroups in patients receiving HAIC combined with lenvatinib plus PD-1 inhibitors or TACE combined with lenvatinib plus PD-1 inhibitors. PFS: progression-free survival; HAIC: hepatic arterial infusion chemotherapy; TACE: transarterial chemoembolization.